Media

Newsroom

Back to news

Galderma Announces U.S. Collaboration with Nespresso®

March 18, 2019

Rewarding Patient Loyalty through Value Incentive Offer on Restylane® Treatments from Aesthetic Professionals

Fort Worth, TX – (March 18, 2019) – Galderma Laboratories, L.P., a global leader focused on meeting the world’s increasing skin health needs, recently announced a new collaboration with Nespresso, the worldwide pioneer and reference in high-quality, portioned coffee. This newest venture brings diversity to Galderma’s existing brand collaborations, offering premier luxury goods to reward patient loyalty and attract new users to the market.

With a qualifying purchase of Restylane dermal fillers, aesthetic professionals will receive a set of vouchers for complimentary Nespresso VertuoPlus machines to offer their patients receiving Restylane treatments. The program is being offered nationally while supplies last.

“Our collaboration with Nespresso provides a unique incentive that caters to the lifestyle and preferences of our patients and aesthetic professionals,” said Alisa Lask, Vice President and General Manager of Galderma’s U.S. Aesthetic Business. “At a time when the market is expanding, we remain committed to supporting its growth and the success of our customers by providing innovative offerings that increase patient retention and drive new users into aesthetic offices.”

The program is being rolled out nationwide based on the success of a pilot program launched earlier this year at select aesthetic offices.

“Building patient loyalty and retention is crucial to the success of my practice, so it’s important that I look for new ways to support my patients and encourage them to return for additional treatments and services,” said Dr. Michael Somenek*, double board certified facial plastic surgeon in Washington, D.C.  “My practice saw a notable response to Galderma’s Nespresso pilot offer, motivating my patients like never before and allowing me strengthen the relationships to enhance their overall experience.” 

This Nespresso collaboration underscores Galderma’s mission to invest in innovations that impact its patients’ lives and customers’ success. Consumers can learn more about this promotion from participating aesthetic providers. To learn more about Nespresso, please visit www.nespresso.com.

*Paid Galderma Consultant

About Galderma
Galderma, Nestlé Skin Health’s medical solutions business, was created in 1981 and is now present in over 100 countries with an extensive product portfolio to treat a range of dermatological conditions. The company partners with health care practitioners around the world to meet the skin health needs of people throughout their lifetime. Galderma is a leader in research and development of scientifically-defined and medically-proven solutions for the skin. For more information, please visit www.galdermausa.com and www.galderma.com.

To earn exclusive rewards, bonuses and discounts on Galderma’s aesthetic treatments, join the ASPIRE Rewards program. To learn more about ASPIRE, visit www.aspirerewards.com.

Contact
Shannon Iwaniuk
Corporate Communications, Galderma
[email protected]

Victoria Smurro
Marina Maher Communications
[email protected] 
212.485.6816

© 2019 Galderma Laboratories, L.P. 
All trademarks are the property of their respective owners.

 

Important Safety Information

The Restylane family of products includes Restylane®, Restylane-L®, Restylane® Lyft with Lidocaine, Restylane® Silk, Restylane® Refyne, and Restylane® Defyne. 

APPROVED USES 
Restylane® and Restylane-L® are for mid-to-deep injection into the facial tissue for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds. Restylane® and Restylane-L® are also indicated for injection into the lips in patients over the age of 21. 

Restylane® Lyft with Lidocaine is for deep implantation into the facial tissue for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds and for cheek augmentation and for the correction of age-related midface contour deficiencies in patients over the age of 21. Restylane® Lyft with Lidocaine is also indicated for injection into the subcutaneous plane in the dorsal hand to correct volume deficit in patients over the age of 21. 
Restylane® Silk is for lip augmentation and for correction of perioral wrinkles in patients over the age of 21. 
Restylane® Refyne is for mid-to-deep injection into the facial tissue for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds, in patients over the age of 21. 
Restylane® Defyne is for mid-to-deep injection into the facial tissue for the correction of moderate to severe deep facial wrinkles and folds, such as nasolabial folds, in patients over the age of 21. 
 

Are there any reasons why I should not use products within the Restylane® family? (Contraindications) 
To ensure a safe procedure, your doctor will talk to you about your medical history to determine if you are an appropriate candidate for treatment. You should not use products within the Restylane family if: 

  • You have severe allergies with a history of severe reactions (anaphylaxis) 
  • You are allergic to lidocaine or to any of the gram-positive bacterial proteins used to make hyaluronic acid 
  • You are prone to bleeding or have been diagnosed with a bleeding disorder

Are there other precautions that I should discuss with my doctor?

  • Tell your doctor if you are breastfeeding, pregnant, or trying to become pregnant. The safety of these products for use during pregnancy, or in women who are breastfeeding, has not been studied
  • Restylane, Restylane-L, Restylane® Lyft with Lidocaine, Restylane Refyne and Restylane Defyne are intended to treat facial wrinkles and folds, such as nasolabial folds. Restylane and Restylane-L are also intended for lip enhancement. Restylane® Lyft with Lidocaine is also intended for injection in the dorsal hand to correct volume loss. Treatments in other areas of the face or body have not been evaluated in clinical studies. 
  • The safety and effectiveness of Restylane® Silk for areas other than the lips and perioral area have not been evaluated in clinical studies. 
  • Tell your doctor if you have any history of scarring, particularly thick and stiff scars, or any pigmentation (skin color) disorders. These side effects can occur with hyaluronic acid fillers in general. 
  • Tell your doctor if you are planning other laser treatments or a chemical peel, as there is a possible risk of inflammation at the treatment site if these procedures are performed after treatment 
  • Patients who experience skin injury near the site of injection with these products may be at a higher risk for side effects 
  • Tell your doctor if you are on any medications to decrease your body’s immune response (immunosuppressive therapy). Using these medications may increase your risk of bruising or bleeding at the gel injection site. 
  • Tell your doctor if you are using any “blood thinners” such as aspirin, warfarin, or any other medications that affect bleeding. Using these medications may increase your risk of bruising or bleeding at the gel injection site. 
  • The use of these products on gel injection sites with skin sores, pimples, rashes, hives, cysts, or infections should be postponed until healing is complete. Use of product in these areas could delay healing or make your skin problems worse. 
  • Tell your doctor if you have diseases, injuries, or disabilities of the hand. 

What are the possible side effects? 
The most commonly observed side effects are swelling, redness, pain, bruising, headache, tenderness, lump formation, itching at the injection site, and impaired hand function. These are typically mild in severity and typically resolve in less than 7 days in nasolabial folds and less than 14 days in lips. Serious but rare side effects include delayed onset infections, recurrence of herpetic eruptions, and superficial necrosis at the injection site. 

One of the risks with using this product is unintentional injection into a blood vessel. The chances of this happening are very small, but if it does happen, the complications can be serious, and may be permanent. These complications, which have been reported for facial injections, can include vision abnormalities, blindness, stroke, temporary scabs, or permanent scarring of the skin. 
As with all skin injection procedures, there is a risk of infection. 
To report a side effect with any of the Restylane products, please call Galderma Laboratories, L.P at 1-855-425-8722.

The Restylane family of products is available only through a licensed practitioner. Complete Instructions for Use are available at www.RestylaneUSA.com.
 

Back to top